Search Results - "Evesque, L."

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300 by Bang, Y.-J, Ruiz, E.Yañez, Van Cutsem, E., Lee, K.-W, Wyrwicz, L., Schenker, M., Alsina, M., Ryu, M.-H, Chung, H.-C, Evesque, L., Al-Batran, S.-E, Park, S.H., Lichinitser, M., Boku, N., Moehler, M.H., Hong, J., Xiong, H., Hallwachs, R., Conti, I., Taieb, J.

“…There currently are no internationally recognised treatment guidelines for patients with advanced gastric cancer/gastro-oesophageal junction cancer (GC/GEJC)…”
Get full text

Cetuximab-related skin toxicity and efficacy: do we understand the mechanisms? by Evesque, L., Francois, E., Milano, G.

Get full text

Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma by Fraunhoffer, N, Hammel, P, Conroy, T, Nicolle, R, Bachet, J-B, Harlé, A, Rebours, V, Turpin, A, Ben Abdelghani, M, Mitry, E, Biagi, J, Chanez, B, Bigonnet, M, Lopez, A, Evesque, L, Lecomte, T, Assenat, E, Bouché, O, Renouf, D J, Lambert, A, Monard, L, Mauduit, M, Cros, J, Iovanna, J, Dusetti, N

“…After surgical resection of pancreatic ductal adenocarcinoma (PDAC), patients are predominantly treated with adjuvant chemotherapy, commonly consisting of…”
Get more information

Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study by Saint, Angélique, Viotti, J., Borchiellini, D., Hoch, B., Raimondi, V., Hebert, C., Largillier, R., Evesque, L., Follana, P., Ferrero, J. M., Delaby, C., Schiappa, R., Chamorey, E., Barriere, J.

“…Purpose Anemia is common in oncology and negatively impacts quality of life. However, there is lack of knowledge about iron deficiency (ID) epidemiology. The…”
Get full text

Regorafenib combined with irinotecan as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas: A randomized phase 2 trial (PRODIGE 58 – UCGI 35 – REGIRI) by Samalin, E., Turpin, A., Khemissa, F., Zaanan, A., Benabdelghani, M., Senellart, H., Gilabert, M., Evesque, L., Dahan, L., Sefrioui, D., Bouché, O., De la Fouchardière, C., Hennequin, A., Monard, L., Gourgou, S., Lopez, A.

Get full text

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202) by Rao, S., Anandappa, G., Capdevila, J., Dahan, L., Evesque, L., Kim, S., Saunders, M.P., Gilbert, D.C., Jensen, L.H., Samalin, E., Spindler, K.-L., Tamberi, S., Demols, A., Guren, M.G., Arnold, D., Fakih, M., Kayyal, T., Cornfeld, M., Tian, C., Catlett, M., Smith, M., Spano, J.-P.

“…Locally advanced or metastatic squamous carcinoma of the anal canal (SCAC) has poor prognosis following platinum-based chemotherapy. Retifanlimab…”
Get full text

Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse by Kinj, R., Doyen, J., Hannoun-Lévi, J.M., Naghavi, A.O., Chand, M.E., Baudin, G., Ferrero, J.M., François, E., Evesque, L., Borchiellini, D., Benezery, K., Bondiau, P.Y.

“…Up to 40% of patients who have received radiation for a pelvic malignancy will develop locoregional recurrence in the previously irradiated volume…”
Get full text

EP-1267: Induction chemotherapy followed by chemoradiotherapy in locally advanced pancreatic adenocarcinoma by Reure, J, Doyen, J, Falk, A, Lam Cham Kee, D, Evesque, L, Follana, P, François, E, Benezery, K

Get full text

Placement of metallic biliary endoprostheses in complex hilar tumours by Maillard, M, Novellas, S, Baudin, G, Evesque, L, Bellmann, L, Gugenheim, J, Chevallier, P

“…Abstract Purpose To assess the technical success, clinical success and complications after 1 month of percutaneous biliary drainage with the placement of…”
Get full text

Use of bevacizumab in elderly patients with metastatic colorectal cancer: Review by François, E, Guérin, O, Follana, P, Evesque, L, Mari, V, Aparicio, T

“…Abstract Significant progress has been made within the last 15 years in the treatment of advanced colorectal cancer. Bevacizumab, an anti-vascular endothelial…”
Get full text

IgG4-related systemic disease: Report of a case in an elderly patient by Couderc, A.L, Evesque, L, Queyrel, V, Sillard, L, Gary, A, Arno, E, Moreau, B, Guérin, O

Get full text

‘Folfirinox’ chemotherapy combined with contact x-ray brachytherapy 50 kVp and ‘CAP50’ chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study by Mitrea, D., Barbet, N., Pacé-Loscos, T., Scouarnec, C., Ben-Dhia, S., Baron, D., Mineur, L., Évesque, L., Durand-Labrunie, J., Gérard, J.-P., Baudin, G., Doyen, J.

Get full text

‘Folfirinox’ chemotherapy combined with contact x-ray brachytherapy 50kVp and ‘CAP50’ chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study by Mitrea, D., Barbet, N., Pacé-Loscos, T., Scouarnec, C., Ben-Dhia, S., Baron, D., Mineur, L., Évesque, L., Durand-Labrunie, J., Gérard, J.-P., Baudin, G., Doyen, J.

“…The standard treatment of T2–T3 rectal adenocarcinoma is radical proctectomy by total mesorectal excision often combined with some neoadjuvant treatment. To…”
Get full text

102P Potentially prognostic factors of overall survival in advanced biliary tract cancer in the randomised phase III TOPAZ-1 study by He, A.R., Bouattour, M., Gupta, V.G., Evesque, L., Zhen, D.B., Park, J.O., Sookprasert, A., Salvatierra, A., Vaccaro, G.M., Oh, S.C., Ostoich, S.A., Satoh, T., Żotkiewicz, M., Rokutanda, N., Kim, H., Oh, D-Y.

Get full text

SO-8 Predictive values of blood-based RNA signature for the FOLFIRINOX/FOLFOX response in advanced pancreatic cancer by Piquemal, D., Noguier, F., Bournet, B., Ghiringhelli, F., Pierrat, F., Canivet, C., Bertaut, A., Bruno, R., Evesque, L., Gamez, A., Cros, J., Lepage, C., François, E., Louvet, C., Vincent, J., Hennequin, A., Bengrine, L., Afchain, P., Trouilloud, I., Bachet, J.

Get full text

Geriatric Assessment in older patients with pancreatic adenocarcinoma by Ciccone, A., Francois, E., Evesque, L., Bereder, I., Boulahssass, R., Guerin, O.

Get full text

LBA23 Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial by Taieb, J., Bouche, O., André, T., Barbier, E., Laurent-Puig, P., Bez, J., Toullec, C., Borg, C., Randrian, V., Evesque, L., Corbinais, S., Buecher, B., Perrier, H., Di Fiore, F., Gallois, C., Lepage, C., El Hajbi, F., Tougeron, D.

Get full text

1204MO PRODIGE 59 - DURIGAST trial: A randomised phase II study evaluating FOLFIRI plus durvalumab and FOLFIRI plus durvalumab plus tremelimumab in second-line treatment of patients with advanced gastric or gastro-oesophageal junction adenocarcinoma by Tougeron, D., Dahan, L., El Hajbi, F., Le Malicot, K., Evesque, L., Aparicio, T., Bouche, O., Bonichon Lamichhane, N., Chibaudel, B., Angelergues, A., A. bodere, Phelip, J.M., Mabro, M., Artru, P., Louvet, C.

Get full text

1617P PRODIGE 29-UCGI 26 (NEOPAN): Quality of life results of a phase III randomised trial comparing chemotherapy with folfirinox (FFX) or gemcitabine (gem) in locally advanced pancreatic carcinoma (LAPC) by Ducreux, M.P., Desgrippes, R., Rinaldi, Y., Di Fiore, F., Guimbaud, R., Evesque, L., Bachet, J-B., Vanelslander, P., Lecomte, T., Capitain, O., Parzy, A., Bolliet, M., Etienne, P.L., Forestier, J., El Hajbi, F., Bignon Bretagne, A.L., Ly Lebrun, V., De Sousa Carvalho, N., Texier, M., Bouche, O.

Get full text

1555P Cell-free DNA analysis in patients with metastatic gastroesophageal adenocarcinoma: Preliminary results of the REGIRI - PRODIGE 58 ancillary study by Harlé, A., Merigout, A., Evesque, L., Turpin, A., Tougeron, D., Botsen, D., Muller, M., de la Fouchardiere, C., Dubreuil, O., Zaanan, A., Bouche, O., Ben Abdelghani, M., Watson, S., Dermeche, S., Khemissa Akouz, F., Husson, M., Merlin, J.L., Bach, A-S., Senellart, H., Samalin-Scalzi, E.

Get full text